Computational disease spread models can be broadly classified into differential equation-based models (EBMs) and agent-based models (ABMs). We examine these models in the context of illuminating their hidden assumptions and the impact these may have on the model outcomes. Drawing relevant conclusions about the usability of a model requires reliable information regarding its modeling strategy and its associated assumptions. Hence, we aim to provide clear guidelines on the development of these models and delineate important modeling choices that cause the differences between the model outputs. In this study, we present a quantitative analysis of how the choice of model trajectories and temporal resolution (continuous versus discrete-event models), coupling between agents (instantaneous versus delayed interactions), and progress of patients from one stage of the disease to the next affect the overall outcomes of modeling disease spread. Our study reveals that the magnitude and velocity of the simulated epidemic depends critically on the selection of modeling principles, various assumptions of disease process, and the choice of time advance. In order to inform public health officials and improve reproducibility, these initial decisions of modelers should be carefully considered and recorded when building and documenting an ABM.
Introduction
Computational models of disease spread processes can be broadly classified into two types: (i) differential equationbased models (EBMs) and (ii) agent-based models (ABMs). For influenza-like illnesses (ILI) and other infectious diseases, computational models are critical for public health officials to understand the effects of disease spread amidst dense urban populations, for predicting the socio-economic effects of major epidemics, and for forecasting the effects of different intervention strategies. [1] [2] [3] While both EBMs and ABMs are widely used in practice, modelers often neglect to examine the impact of different modeling choices and assumptions decided in the early stages of model development.
EBMs model the population by segmenting it into different compartments, such as susceptible (S), infected (I), and recovered (R), with each compartment representing a stage in the progression of the disease. 2 Additional compartments can be defined based on model requirements. Transitions between each of the compartments capture the overall dynamics of the epidemic, showing how the population as a whole gets infected and eventually recovers. EBMs capture aggregate behaviors over the whole population. Individuals and interactions between individuals are omitted from EBMs, and so these models can be used with relatively little computational power and relatively small amounts of input. Therefore EBMs can capture large-scale (including country-wide/continent-wide pandemic) disease spread with relatively little effort.
On the other hand, ABMs include individual level information to capture how people interact and participate in different activities (work, school, exercise, etc.). describe models that incorporate individual entities (or agents that can be autonomous, heterogeneous and/or adaptive) and are developed by emphasizing the progression of the individual (and his/her behavior) over the course of the disease. While individuals within a community undergo a similar disease progression as in EBMs, the outcomes from the ABMs are largely determined by the interaction between these individuals and the data that characterize the interactions.
Previous research on comparing epidemiological models has largely focused on the comparison of different models and their outcomes without considering the underlying assumptions and implementations specific to these models. Rahmandad and Sterman 6 examined the choice between EBMs and ABMs from the perspective of heterogeneity in individual populations and the network topology of interactions, including fully connected, random, small-world, scale-free, and lattice networks. The authors found that the EBM and ABM implementation based on the different network models differed significantly in terms of their outcomes including diffusion speed (the amount of time that passes until the peak load is observed), peak load on health services (the maximum infectious proportion of the population observed over time), and total disease burden (cumulative number of people who died from the disease at the end of the epidemic). Further, the authors speculate that the differences in the outcomes could be a consequence of the differences in network topologies, heterogeneity (amongst individuals in the population), and discretization of stochastic interactions between agents. However, they also observe similar differences for the homogenous population. In their homogenous population scenario, the differences in the output trajectories can originate from stochasticity or modeling assumptions examined in our work. Unless the model assumptions are explicitly documented, we cannot determine how much stochasticity or modeling assumptions contributed to their conclusions.
Ajelli et al. compared an ABM that is based on census data of Italy with a structured meta-population model named Global Epidemic and Mobility (GLEaM) 7 that was designed to predict spatio-temporal aspects of global epidemics by incorporating International Air Transport Association (IATA) data. 8 Despite the similarity of results regarding the disease propagation at different locations, this comparison did not provide details on underlying modeling principles and assumptions in the two distinct models. Jaffry et al. qualitatively compared the results from an EBM and an ABM and noted that the differences in the results were a consequence of the sampling variability. 9 Similarly, Macal claimed that disagreements between agent-based and system dynamics models of epidemiology are caused by stochasticity. 10 Kennedy et al. applied a variety of validation techniques to one EBM and one ABM and addressed the importance of knowing the abstraction (i.e., conceptual model) and implementation decisions when comparing models. 11 Cross-validation techniques, 12 sensitivity analyses, 13 and other statistical techniques 14 have been used to analyze EBMs and ABMs. Although understanding how distinct models can have similar behaviors based on their input parameter values is valuable, it is difficult, in general, to distinguish whether the results are a consequence of the calibration process or modeling assumptions and the specific implementation used in the models.
In this study, we present our analyses of the effect of the modeling approach with ABMs and EBMs using 1918 flu pandemic parameters. Our goal is to demonstrate our results via a realistic scenario. The 1918 flu, referred to as the Spanish flu, was an exceptionally deadly and widespread pandemic which resulted in over 50 million deaths worldwide. 15 With nearly a third of the world population infected, and an increased case fatality over other types of flu, this pandemic represents a widely studied phenomenon within modern infectious disease epidemiology.
Our analysis examines three aspects of susceptibleinfected-recovered (SIR) 16 models; these are (i) the choice of an individual-based (ABM) or population-based (EBM) approach; (ii) the underlying assumptions in modeling the disease process; and (iii) temporal resolution. We assess the effects of the aforementioned modeling choices on the behavior of large-scale epidemiological simulations for a realistic scenario.
For this purpose, we develop a family of models that are closely related to the basic SIR. Each model highlights a specific choice of EBM versus ABM and the accompanying mathematical assumptions concerning the disease process within an individual, interactions between individuals, and the temporal resolution with which the model evolves. Using these models, we make an explicit study of how the underlying mathematical structures of these models can result in different outcomes in spite of their shared conceptual underpinnings; specifically, we examine the following.
I.
The choice of model trajectories and their attendant temporal resolution. This may be continuous or discrete-event, which both have systems evolve in time over the real numbers, or discrete-time, which has systems evolve in time over the natural numbers. II. The nature of the couplings between agents, which may be instantaneous functions (e.g., as occurs in EBM models and in some discrete-time and discrete-event models) or a delay function (e.g., as occurs in many discrete-time models). III. The mathematical process of progressing through the SIR compartments, which may be governed by a linear process (i.e., as in most EBMs) or with a non-linear delay (i.e., as in most ABMs).
In a majority of scenarios considered here, the choice of ABM (i.e., individual-based) versus EBM (i.e., population-based) model has no impact on the aggregate (i.e., population-level) dynamics of an epidemic when the models agree on the mathematical processes for disease spread (II and III above) and temporal resolution (I above). This suggests that the question of ABM versus EBM is of practical interest only when parameters are at certain limits or some particular use of the model depends on a quantity made visible by its agent-based version (e.g., the network of interactions between individual agents). However, differences between models in any of the above traits can cause substantive differences in outcomes.
Methods
In this section, we describe the input parameters and modeling decisions in detail. To facilitate a meaningful comparison of models constructed with different tools and using different modeling approaches, we impose the following conditions on all of the models. 
Parameters for the 1918 influenza pandemic
A previous study of the 1918 flu pandemic 17 provides estimates of the disease spread parameters, and these parameters are used in the current study. The parameters were kept consistent across the six EBMs and ABMs used herein and were specific to the disease and population within the United States during the 1918 pandemic. A summary of the different parameters and their values are shown in Table 1 . Note that we used only a small number of parameters in this study in order to balance the complexity of the models versus the actual observations of the 1918 pandemic. In order to make the models computationally feasible, we scaled the population of the United States in 1918 from 103 million to about 500,000. Note that this is an assumption that is practiced in the former analysis 17, 18 and the findings are scaled to reflect the actual population.
Previous studies estimate the number of deceased within the United States to be between 550,000 and 675,000 during the 1918 influenza outbreak. 15, 19 This number can be used to estimate pm (i.e., the probability of death given that a person has contracted the flu) based on the estimated number of infected people which corresponds to approximately 50% of the population 19 at that time. However, these estimates are likely lower than the actual numbers due to under-reporting of incidents and long-term fatality rates. Moreover, the methods used to collect the data can be biased reflecting impacts of demographic and geographic factors. Regardless, the estimates used in this study are selected from the parameter ranges given in previous studies.
An important parameter in epidemiology is the R 0 value. This value is the average number of secondary cases caused by a primary infectious individual. 2 Assuming a fully susceptible population, when the basic parameter notation and values (shown in Table 1 ) are used, the R 0 value is calculated using the following:
According to Chowell et al., 20 the R 0 of the 1918 influenza pandemic varies between 1:5 to 2:0 depending on which wave of the pandemic is considered. The 1918 influenza occurred in different seasons with distinct peaks observed for each wave of the pandemic. This study uses the value of R 0 '1:8, which is within this range.
Equation-based disease spread models
In the previous section, we explained the choice of parameters used in all the models developed. In this section, we describe the individual models. In SIR models, the population is divided into three compartments: susceptible (S), infectious (I), and recovered (R). The dynamics of the disease spread process are captured by the interactions between these compartments, which are modeled as ordinary differential equations (ODEs). In the following sections, we describe variations of the EBMs that mimic the SIR dynamics.
2.2.1. Simple SIR model. To account for the large number of deaths caused by the 1918 pandemic, we modify the traditional SIR model to include an additional compartment for the deceased population (represented as D within the model). The R population is still maintained to represent immune individuals who were sick and have recovered.
Together with R and D, we create an aggregate compartment, termed the removed (Re) population. Figure 1 represents the compartments used in the models. Using those state variables and parameters, the dynamics of this SIR model is described by the following set of equations:
The expression for (d=dt)Re in Equation (2) makes a significant simplification that assumes the infectious population is homogeneous. At each instant of time, the model estimates a fraction (1=tr) of the infectious population will recover regardless of the day of infection for those population members. To understand how this simplification affects the model's evolution, suppose that Re(t = 0) = 0, I(t = 0) = 0, and that everyone recovers (i.e., pm = 0). By fixing (d=dt)I = K, we may ignore the susceptible population S and assume that the number of infected people increases at a constant rate K. We may rewrite the model as:
and the recovered population at time t is therefore:
However, if each infected individual recovers in tr days then we should expect the recovered population at time t to equal the infected population at time t À tr. That is, we should expect:
Hence the recovered population predicted by the SIR model and the recovered population that would actually be generated by the disease process are not the same. To correct this error, we develop a slightly more elaborate model that is described in the following section.
SIR model with substates.
The simplifying assumptions in the previously described SIR model can be countered by introducing substates I 1 , I 2 , ., I V with V = tr=Dt b c, and
where Dt is the resolution in time with which the progress of the disease is modeled. These substates represent the number of people in their first period of infection, in their second period of infection, and so on. Figure 2 represents the logic behind the division of the model compartments.
Assuming that TI is the total infectious population that will recover and TD is the total infectious population that will die, the EBM model incorporating these substates noted above can be described by the following set of ODEs: The introduction of the different substates overcomes the simplification in the EBM-SIR described previously, but it can run into the issue of dividing the population into a large number of compartments as Dt ! 0. To overcome this shortcoming, we introduce a SIR model that has a delay in the following section.
SIR model with delay.
In this model, the substates are replaced by a delayed differential equation that is the limit of the substate model as Dt ! 0. In this model, two discontinuities appear, namely: (i) an event where there is a sudden jump at tm of the deceased population (i.e., to account for the deaths of the initially infected persons) and (ii) an event where there is a sudden jump at tr of the recovered population. To overcome these discontinuities we incorporate two discrete events. For the first event that occurs at t = tm, we (i) make deceased jump from zero to infectious(t = 0) 3 pm and (ii) remove infectious(t = 0) 3 pm (deceased persons) from the infectious population. For the second event that occurs at t = tr, we (i) cause recovered to switch from zero to infectious(0) 3 (1 À pm) and (ii) remove the recovered from the infectious pool. The equations for this delayed model with its two discrete events are:
The SIR model with delay represents an additional refinement of the models presented above. We next describe the construction of three ABMs reflecting the same processes of disease spread as those explained above.
Agent-based disease spread models
ABMs use detailed representations of individual entities (i.e., humans) to model micro-level interactions among individuals. However, there are different approaches to advancing time in the model (event-based vs time-stepped) and handling the interactions between individuals in ABMs. Therefore, in the following sections, three variations of agent-based implementations for the modified SIR dynamics are introduced.
2.3.1. Event-based SIR model. Our first ABM is a discreteevent model, and this model is built by decomposing the population of the delayed SIR model into its individual agents. In this ABM, the progress of the disease is modeled explicitly for each agent and transmission of the disease occurs through daily contact between individual agents. Each agent is described by the coupled discrete event system (DEVS) specification 21 shown in Figure 3 . A DEVS model is comprised of atomic and coupled models. An atomic model is a state transition system as defined by Zeigler et al., 21 which has a set of states S, a set of inputs X, and set of outputs Y. An output function l : S ! Y defines the output produced by a model when in a given state, and this output occurs after an interval given by the time advance function ta : The DEVS model defined here has three atomic models: the exposure process, the disease process, and the infectious process. The exposure process initiates disease in the agent upon receipt of an infect event from some other infectious agent. Upon receipt of its first infect event, the exposure process forwards this event to the disease process and the infectious process. The exposure process then becomes inert, thereby making the agent immune to infection through new contact with other infected agents. The disease process models the progression of the disease through its stages, and determines the outcome for that agent.
A sick agent transmits the disease to other agents through its infectious process. The infectious process sends infect events to other agents at a rate determined by the number of expected encounters per day. An infect output generated by the infectious process of agent i becomes an infect input for an agent j 6 ¼ i selected at random from the set of agents that are alive at the time of the output. The mathematical formulation of these three processes is given below. Exposure process. The exposure process begins a period of infection for the agent. The exposure process has the single state variable stage that may take the values 0, 1, and 2. The initial value is stage = 1 if the agent begins with the disease and stage = 0 otherwise. If stage = 2, then the agent has already been infected. The dynamics of the exposure process are given by:
Disease process. The disease process carries the agent through the stages of the disease. The disease process has a state variable stage that may take the values deceased (D), recovered (R), dying (Dy), recovering (R Ã ), and susceptible (S). The initial state is stage = susceptible. A uniformly distributed random variable u with range ½0, 1 is used to determine the outcome of the disease for this agent. The dynamics are:
Infectious process. The infectious process is responsible for causing other agents to be exposed to this agent while the agent is infectious. The infectious process has a Boolean-valued state variable infectious; a random variable u uniformly distributed in ½0, 1 is used to determine if a particular encounter will lead to infection of the encountered agent; and an exponentially distributed random variable m with mean 1=re is used to determine the time between encounters. The initial value of infectious is false. The dynamics of the infectious process are given by:
2.3.2. A time-stepped SIR model with two forms. The models described above incrementally refine the implementation of the disease spread process. All of the above models have two features in common: (i) interactions happen instantaneously and (ii) the state of the model can change at any instant of the real-valued simulation clock. The models described in this section eliminate these two features by using a discrete-time, rather than continuous-time, approach to model construction. Discrete-time (i.e., timestepped) models are a popular type of ABM, and this approach is the basis of most modeling tools for agentbased systems.
Our time-stepped ABM is implemented using the Repast framework, 23 and it departs from the above models (EBMs and the event-based SIR model) in two specific ways. First, this ABM may delay interactions between agents: one variant of the model uses instantaneous interactions and the other does not. Second, this model has a discrete time base and the states of its agents change at fixed instants t 0 , t 1 , t 2 , . that are separated by the model's time increment h (i.e., t n + 1 À t n = h).
At each step of the simulation, the agents are activated in an order that is generated at random. In Repast, this procedure for activating agents is called ''scheduler scramble.'' 24 Upon activation, an infected agent draws the number of agents to contact for that time step from a Poisson distribution with mean re. The Poisson distribution is used for two reasons. First, it is necessary to draw the number of people to encounter from a discrete distribution: an agent cannot encounter part of a person. Second, inter-encounter times in the event-based model are drawn from an exponential distribution, and the Poisson distribution is its natural counterpart. Two different approaches, corresponding to two different forms of the time-stepped model, are used to calculate a new state for the agent and the agents it contacts, as follows.
Form 1: Asynchronous interaction.
In this approach to updating the agents' states, if Agent A infects Agent B at time t, then the state of Agent B is updated immediately. Hence, there can be two cases: (i) Agent B was activated before Agent A, so Agent B waits until t + 1 to infect other agents, or (ii) Agent B is activated after Agent A, so Agent B starts passing along the infection at time t.
Form 2: Synchronous interaction. In this process, if Agent A infects Agent B at time t, Agent B becomes infected at time t + 1 regardless of the order of agent activation. Moreover, agents observe the state of other agents as the state that existed before agent activation began. For example, if Agent A infects Agent B and the next agent to be activated is Agent C, then Agent C perceives Agent B as susceptible, not infected. This process allows an infected agent to pick an already infected agent to pass the infection along.
Obtaining comparable outputs from EBMs and ABMs
For ABMs described here, the state variable stage of the disease process model is used to construct the quantities deceased, recovered, infectious, and susceptible. For ABMs, the quantities deceased and recovered in the respective EBMs correspond to the count of agents with stage = D and stage = R, respectively. The quantity susceptible in EBMs corresponds to the count of agents with stage = S in ABMs. The quantity infectious in the EBMs corresponds to the sum of the number of agents with stage = Dy and stage = R Ã in the ABMs. In the timestepped ABMs, similar to the event-based ABMs, the number of agents that match the corresponding state are counted at the end of each time tick. The only exception is the quantity deceased; deceased is just the number of agents that are removed from the environment in the timestepped model.
Results
In this section, we start with comparisons of point estimators. Subsequently, we focus on the evolution of outputs over time. The differences between the model outputs are delineated in both quantitative and qualitative manners.
Peak load, diffusion speed, and disease burden
Three metrics in particular are important for policy makers when considering how to respond to an outbreak of influenza. These metrics are peak load on health services, defined here as the largest infectious population observed over time; diffusion speed, defined as the amount of time that passes from the initial outbreak until the peak load is observed; and total disease burden, defined as the cumulative number of people who have died from the disease at the end of the epidemic. Table 2 compares these metrics across the six models with parameters for the 1918 flu epidemic as previously described. At the 95% confidence level, the EBM-delayed and event-based ABM are indistinguishable. The diffusion Table 2 . Peak load, diffusion speed, and total burden of different models.
Models
Peak Load ( ± 95%CI) Diffusion Speed ( ± 95%CI) Total Burden ( ± 95%CI) EBMs of this study are deterministic, and hence do not have variability. The 1918 influenza data value is found by scaling the real-world estimates down based on the population size used in experiments. Confidence intervals (CI) assume normality.
speed and total burden of the EBM-delayed model is within the 95% confidence interval for the diffusion speed and total burden of the event-based ABM. The peak load for the event-based ABM is slightly higher than that of the EBM-delayed model, but only by 79 persons out of 500,000 people in relation to the lower bound on the 95% confidence interval. The difference in the peak load measures from the two models is just 0:07% of the 114,480 (out of 500,000 as the initial population; Table 1 ) of the EBM-delayed model, implying that these models differ very little with respect to this metric. It is also interesting to note that the other models differ significantly with respect to the peak load values, with the EBM-SIR model estimating the lowest peak load compared to the other models. This is also expected since the EBM-SIR model incorporates a significant simplification in the recovery/ death process as aforementioned. However, one can observe that the comparisons with other models are not the same. While there is significant agreement between the event-based model and the timestepped-asynch model, the time-stepped-synch model differs considerably with respect to the diffusion speed. As such, the event-based and time-stepped-asynch models suggest that the initial rise in the number of sick people is similar in both cases, implying similar disease propagation. However, for the time-stepped-synch model, the disease spreads more slowly reaching a lower peak load. The variation of diffusion speed is also true for comparisons between the time-stepped models and the EBM-delayed model and comparisons between the three EBMs.
The total burden measures an equilibrium state of the model. Specifically, for the three different EBMs, the total burden measures the overall number of deceased people and, for the ABMs, indicates the maximum number of deceased agents when the model becomes quiescent. Table  2 suggests that the equilibrium states for the six types of models are very similar, in spite of not sharing any common disease progression trajectories. The two other observables, namely the peak load and diffusion speed, measure transient aspects (see the next section) of the models, and therefore depend on measurements of the state variables when the derivatives are far from zero (for the EBMs) or the agents are active (for the ABMs). Therefore, we can conclude that the transient dynamics for these six models are quite different with the exception of the event-based and EBM-delayed models. For these two models, we should expect similar transient behavior because the two models agree with respect to peak load and diffusion speed.
Transient behavior
To probe the changes in the transient behavior, we performed additional analyses on the models. Figure 4 shows trajectories for each of the six models with parameters for the 1918 flu epidemic. This figure shows the (S) susceptible, (I) infectious, (R) recovered, and (D) deceased population as a proportion of the total population at the end of each simulated day. The EBMs are deterministic and so the trajectories shown are the model's only possible output for the given parameters and initial conditions. The ABMs are stochastic, and the trajectories shown in Figure 4 represent the mean values and the 95% confidence interval to indicate typical evolution of the models.
There is a general agreement in terms of the overall shapes of trajectories generated by each model. While the trajectories closely resemble one another in terms of the final outcomes (as observed previously in terms of the equilibrium measures), there are significant differences regarding their transient dynamics. In Figure 4 (S), it is quite clear that EBM-SIR (orange line) shows S decreasing much more slowly than do the other models. Similarly, in Figure 4 (I), (R), and (D), the disease propagation in the EBM-SIR is slower. This discrepancy between the EBM-SIR and the other models is anticipated because of the simplification in the EBM-SIR model. The subsequent corrections to the EBM-SIR model, first by adding substates and then adding delays, brings the trajectory of the EBM-SIR model very close to that of the event-based ABM.
It is much more difficult to explain the differences between the EBMs and ABMs. The substantial difference between the time-stepped-synch and -asynch ABMs is particularly noteworthy. The choice of a synchronous versus asynchronous updating strategy has a large effect on the models' trajectories. The synchronous strategy spreads the disease more slowly, and we hypothesize that this observation is due to the delay between the exposure of an agent to the disease and that agent becoming infectious. This notion is reinforced by the trajectories of the time-stepped ABM model that uses an asynchronous updating strategy, for which such a delay does not exist. Indeed, the timestepped-asynch model much more closely approximates the trajectories of the EBM-delayed and the event-based ABM models. We tested the aforementioned hypothesis with simulations of both time-stepped models using successively smaller time steps. The results are presented in Figure 5 (a) and (b) for asynchronous update and in Figure  5 (c) and (d) for synchronous update models. Specifically, in Figure 5 (a) and (c), it is clear that the discrepancies between curves gradually diminish as the time steps are successively reduced (h = 1:0, 0.5, 0.2, 0.1, and 0.05 days). This diminishing size of the time step has two effects: first, it causes the discretization of time in both of the time-stepped models to better approximate the continuous time used in the EBM and the event-based model; second, it causes the one-step delay between exposure and infection in the synchronous model to more closely approximate the instantaneous infection that occurs in the other models. These two effects are both significant in determining the outcome of the model. As the time step is reduced, the trajectories of the time-stepped models resemble one another more closely, approaching the trajectories of the EBM-delayed model, and the trajectories of the eventbased model. This suggests that the selection of a time base, either continuous or discrete, has important consequences for a model's dynamic behavior. Moreover, if the time base is discrete, then the size of the time step also has a substantive effect on the model's behavior. Hence, the problem of choosing a representation for time is an important, but often overlooked, aspect of building and using ABMs, most of which use a discrete time base and rely on the modeler's intuition to choose a time step.
The choice of an asynch or synch updating strategy has important ramifications. The behaviors of both timestepped models are quite distinct when their time step is one day. This difference only diminishes as the time step becomes smaller and, consequently, the differences between the update strategies become less significant. This section highlights the importance of choosing when and how agents interact within a model (see Section 4).
Sensitivity to small encounter rates
The number of opportunities for a sick person to encounter healthy persons is a major factor in the rate and extent of an epidemic. In our models, this is captured by the encounter rate. The encounter rate, re, is one of the epidemicrelated parameters that has a high impact on the R 0 value. Small values of re are of particular interest for comparing ABMs and EBMs. If re is small enough, the EBM will always indicate that the epidemic falters and ABMs might generate highly variable outcomes.
The cause for this is clearly apparent in the term for (d=dt)I in the SIR model presented in Equation (2) . Near the start of the epidemic, we may take S=(S + I + R)'1 and so write (d=dt)I as:
from which it follows that I grows if and only if:
and rearranging this expression shows that growth requires:
re . 1 pt pm tm
For the parameters given in Table 1 , the above expression indicates that re . 2:27 is required for growth in the EBM-SIR. Note that a similar argument holds for both EBM-substates and EBM-delayed.
Although the absolute lower bound for the disease to propagate within the ABMs is 0, note that with re 4 2:27 the disease in an ABM is most likely to spread to a very small number of persons before the epidemic dies out. Hence, the infectious population will grow slightly before shrinking to zero in the event-based model. This expected behavior is different from the behavior of the EBMdelayed where the number of infectious people is strictly diminishing. Moreover, with the ABMs there is a small but definite chance that the infectious population will become quite large and the disease will spread very rapidly. This is a scenario that cannot be captured by the EBMs.
Indeed, numerical experiments show that the eventbased ABM and EBM-delayed models agree for relatively large values of re. However, for simulations with re 4 2:27 the agreement between EBM and ABM is much less pronounced 25 even though disease propagation is mitigated in both models. This fact is illustrated in Figure 6 which shows the mean absolute percentage error (MAPE) for the number of deceased when comparing the EBMdelayed model and event-based ABM. The MAPE is defined by:
where M is the MAPE, t is the number of days that the disease spread continues, and O t and E t are the cumulative number of deceased at day t for the EBM-delayed and event-based models, respectively. In Figure 6 it can be seen that the level of disagreement increases significantly Figure 6 . EBM-delayed vs event-based model: MAPE between the cumulative numbers of deceased.
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